| Literature DB >> 12469196 |
Myung-Jin Park1, In-Chul Park, Hyung-Chan Lee, Sang-Hyeok Woo, Jae-Young Lee, Young-Joon Hong, Chang-Hun Rhee, Yun-Sil Lee, Seung-Hoon Lee, Bum-Sang Shim, Toshino Kuroki, Seok-Il Hong.
Abstract
In the present study, phorbol 12-myristate 13-acetate (PMA) was found to increase secretion of matrix metalloproteinase (MMP)-9 and in vitro invasion in bovine capillary endothelial (BCE) cells, which were blocked by specific inhibitors of protein kinase C (PKC). To elucidate molecular mechanisms involved, we studied the effect of PMA on the activation of mitogen activated protein kinases (MAPKs), and found that PMA activated extracellular signal-regulated kinase (ERK)1/2 and PD98059, a specific inhibitor of MAPK kinase, significantly reduced PMA-induced MMP-9 secretion as well as in vitro invasion of BCE cells. Treatment of safingol, a specific PKC-alpha inhibitor, and introduction of antisense PKC-alpha into these cells reduced the secretion of MMP-9 and activation of ERK1/2 by PMA. Furthermore, we employed adenoviral PKC-alpha and found that weak PMA stimulation (5 ng/ml) enhanced ERK1/2 activation and MMP-9 secretion in these cells. Therefore, we strongly suggest that PKC-alpha, partly at least, have a crucial role in MMP-9 secretion and invasion of BCE cells which are mediated via ERK1/2 signaling pathway.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12469196
Source DB: PubMed Journal: Int J Oncol ISSN: 1019-6439 Impact factor: 5.650